title: Reply: To PMID 23591271.
authors.affiliation: Genentech, South San Francisco, Calif. Electronic address: rosen.karin@gene.com.
authors.forename: Karin
authors.initials: K
authors.lastname: Rosén
authors.affiliation: Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
authors.forename: William
authors.initials: W
authors.lastname: Busse
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001249:Asthma / Q000628:therapy*; D015415:Biomarkers / Q000032:analysis*; D004802:Eosinophilia; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000628:therapy*; D008297:Male
chemical_list: D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D015415:Biomarkers